| |

Critical Reviews™ in Therapeutic Drug Carrier Systems

Impact factor: 3.038

Critical Reviews™ in Therapeutic Drug Carrier Systems
 
 

ISSN: 0743-4863 Print

  You can order a single issue or an individual article, as well as view the table of contents or article abstract by clicking on the volume number, then the issue number in the right sidebar.  

Institutional price: $1150.00

Online subscription
Add subscription to shopping cart
click 'Save as...' here to save XML metadata   Year 2005, Volume 22 / Issue 6

Pages: 122

Article price - $90.00 Add to shopping cart

Biodegradable Microspheres for Parenteral Delivery


ABSTRACT

Nowadays, emphasis is being laid to development of controlled release dosage forms. Interest in this technology has increased steadily over the past few years. Although oral administration of drugs is a widely accepted route of drug delivery, bioavailability of drug often varies as a result of gastrointestinal absorption, degradation by first-pass effect, and hostile environment of gastrointestinal tract. Transdermal administration for percutaneous absorption of drug is limited by the impermeable nature of the stratum corneum. Ocular and nasal delivery is also unfavorable because of degradation by enzymes present in eye tissues and nasal mucosa. Hence, the parenteral route is the most viable approach in such cases. Of the various ways of achieving long-term parenteral drug delivery, biodegradable microspheres are one of the better means of controlling the release of drug over a long time. Because of the lipidic nature of liposomes, problems such as limited physical stability and difficulty of freeze-drying are encountered. Similarly, for emulsions, stability on long-term basis and in suspensions, rheological changes during filling, injecting, and storage poses limitation. Also, in all these systems, the release rate cannot be tailored to the needs of the patient. Parenteral controlled-release formulations based on biodegradable microspheres can overcome these problems and can control the release of drug over a predetermined time span, usually in the order of days to weeks to months. Various FDA-approved controlled-release parenteral formulations based on these biodegradable microspheres are available on the market, including Lupron Depot® Nutropin Depot® and Zoladex®. This review covers various molecules encapsulated in biodegradable microspheres for parenteral delivery.


pages 535-602


<< Previous article   Next article >>

 
begell house, inc.
publishers
50 Cross Highway
Redding, CT 06896
Tel.: (203) 938 1300
Fax: (203) 938 1304